Biomerica Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the fourth quarter 2026, Biomerica Inc 's inventory turnover ratio sequentially decreased to 2.59 in the fourth quarter 2026, otherwise the ratio remained above the average, as BMRA's markets remain strong.Biomerica Inc 's average inventory processing period in the May 31 2026 quarter, has increased to 141 days, from 134 days, in the Feb 28 2026 quarter.

Within Healthcare sector 151 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1301 in the third quarter 2026, to 1316.

BMRA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Biomerica Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BMRA Inventory Turnover Ratio	(May 31 2026) IV. Quarter	(Feb 28 2026) III. Quarter	(Nov 30 2025) II. Quarter	(Aug 31 2025) I. Quarter	(May 31 2025) IV. Quarter
Y / Y Inventory Growth	14.56 %	-0.6 %	-37.29 %	-24.15 %	-37.29 %
Y / Y Cost of Sales Growth	-5.12 %	-6.27 %	-3.34 %	-37.02 %	-9.04 %
Inventory Turnover Ratio (TTM)	2.59	2.72	2.76	2.43	2.58
BMRA's Total Ranking	# 1316	# 1301	# 51	# 355	# 1104
Average inventory processing period	141	134	132	150	141
Seq. Inventory Growth	3.77 %	10.4 %	1.15 %	-1.14 %	-9.97 %
Seq. Cost of Sales Growth	-8.34 %	-11.04 %	21.23 %	-4.02 %	-9.45 %

Inventory Turnover Ratio Company Ranking
Within:	No.
In Vitro & In Vivo Diagnostic Substances Industry	# 7
Healthcare Sector	# 152
Overall Market	# 1316

Inventory Turnover Ratio Statistics
High	Average	Low
6.03	2.36	1.64
(Aug 31 2022)		(Nov 30 2020)

BMRA Company Profile >> Back to BMRA Efficiency Comparisons >> Compare BMRA Inventory Turnover Ratio to its Competitors

Financial Statements
Biomerica Inc 's Inventories	$ 2 Millions	Visit BMRA's Balance sheet
Biomerica Inc 's Cost of Revenues TTM	$ 4 Millions	Visit BMRA's Income Statement
What are BMRA's Sales?		Visit BMRA's Sales by Segment

Other Inventory Turnover Ratios
Biomerica Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
In Vitro & In Vivo Diagnostic Substances Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BMRA's Inventory Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BMRA's Competitors
Inventory Turnover Ratio for BMRA's Suppliers
Inventory Turnover Ratio for BMRA's Customers

You may also want to know
BMRA's Sales Growth Rates	BMRA's Pe Price to earnings ratio	BMRA's Receivables Turnover Ratio	BMRA's Stock Quote
BMRA's Net Income Growth Rates	BMRA's Ps Price to Sales ratio	BMRA's Sales per Employee	BMRA's Asset Turnover Ratio
BMRA's Net Margin	BMRA's Pb Price to Book ratio	BMRA's Financial Strength Ratios	BMRA's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending May 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending May 31 2026	Inventories at quarter ending May 31 2026
Brightspring Health Services Inc	6.35	$ 4,108.953 Millions	$ 647 Millions
Puma Biotechnology Inc	6.29	$ 58.199 Millions	$ 9 Millions
Kewaunee Scientific Corporation	6.12	$ 196.836 Millions	$ 32 Millions
Adm Tronics Unlimited Inc	6.05	$ 1.970 Millions	$ 0 Millions
Align Technology inc	6.00	$ 1,321.762 Millions	$ 220 Millions
Sharps Technology Inc	5.68	$ 2.869 Millions	$ 1 Millions
Transmedics Group Inc	5.59	$ 276.120 Millions	$ 49 Millions
Cg Oncology Inc	5.47	$ 7.609 Millions	$ 1 Millions
Opko Health Inc	5.42	$ 348.206 Millions	$ 64 Millions
Charles River Laboratories International inc	5.39	$ 1,761.363 Millions	$ 327 Millions
Bristol myers Squibb Company	5.37	$ 14,678.000 Millions	$ 2,735 Millions
Tactile Systems Technology Inc	5.12	$ 81.349 Millions	$ 16 Millions
Integer Holdings Corporation	5.03	$ 1,369.168 Millions	$ 272 Millions
Collegium Pharmaceutical Inc	4.99	$ 293.290 Millions	$ 59 Millions
Harrow Inc	4.93	$ 73.636 Millions	$ 15 Millions
Ufp Technologies Inc	4.93	$ 452.046 Millions	$ 92 Millions
Veracyte Inc	4.84	$ 102.741 Millions	$ 21 Millions
West Pharmaceutical Services Inc	4.72	$ 2,103.100 Millions	$ 445 Millions
Henry Schein Inc	4.68	$ 9,342.000 Millions	$ 1,997 Millions
Guardant Health Inc	4.53	$ 413.947 Millions	$ 91 Millions
Idexx Laboratories Inc	4.44	$ 1,714.440 Millions	$ 386 Millions
Cryoport inc	4.40	$ 98.679 Millions	$ 22 Millions
Envista Holdings Corporation	4.37	$ 1,278.500 Millions	$ 293 Millions
Vericel Corporation	4.30	$ 77.922 Millions	$ 18 Millions
Myomo Inc	4.23	$ 14.262 Millions	$ 3 Millions
Adc Therapeutics Sa	4.17	$ 5.806 Millions	$ 1 Millions
Scilex Holding Company	4.08	$ 14.867 Millions	$ 4 Millions
Medinotec Inc	4.08	$ 4.736 Millions	$ 1 Millions
Alpha Teknova Inc	4.08	$ 28.288 Millions	$ 7 Millions
3m Company	4.07	$ 15,258.000 Millions	$ 3,754 Millions

Date modified: 2026-09-05T08:34:47+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.